• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Targeted Therapy a Potential Treatment for Head and Neck Cancer

by Heather Lindsey • May 1, 2006

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

The combination is a useful and viable option for patients who need chemoradiation but cannot tolerate cisplatin or other types of chemotherapy, added Dr. Cohen. For the many patients who are elderly or have poor kidney function or other significant comorbid conditions such as heart failure or diabetes, cetuximab with radiation provides a more effective treatment option than radiation alone and is well tolerated.

You Might Also Like

  • Targeted Therapies + Chemo Show Activity in Recurrent/Metastatic Head And Neck Cancer
  • New Treatment for Head and Neck Cancer Means Longer-Lasting Toxicity
  • A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?
Explore This Issue
May 2006

The blanket statement that chemoradiation therapy is the standard of care for advanced disease is troublesome for me, said Dr. Strome. Stage 3 cancers, for example, can have small primary tumor sites that can be treated with endoscopic surgery, while avoiding the side effects of chemoradiation.

More and more head and neck surgeons are doing endoscopic surgery for small primary lesions in the voice box and pharynx, said Dr. Strome. For example, some patients with T-2 lesions of the larynx with a positive neck node can be out of the hospital in five days, and talk and swallow within two weeks.

The problem is, a lot of people don’t understand what modern surgery can accomplish as opposed to 10 years ago, he said. I can take a small tumor out through the mouth with a laser and cryotherapy. While not all centers offer this treatment, patients need to understand it is an option.

Impact on the Otolaryngologist’s Role

The impact of cetuximab and other biological agents on otolaryngologist-head and neck surgeon’s role in providing care for head and neck cancer patients is significant, said Robert Dolan, MD, Senior Staff in the Lahey Clinic Medical Center’s Department of Otolaryngology-Head and Neck Surgery in Burlington, Mass.

While the agent appeared to be beneficial for oral pharyngeal cancer, it did not make any difference in outcomes in patients with larynx or hypopharyngeal cancer.

Counseling the patient regarding prognosis may be impacted, he said. For example, if the outcome of the phase III clinical trials using cetuximab is positive as anticipated, then the otolaryngologist may justifiably predict an improved outcome with regard to tumor control and ultimately survival, he explained.

The otolaryngologist will also need to be aware of the potential side effects of cetuximab. In the long term, there is a potential for these biologic agents to supplant standard chemotherapy either as single agents or more likely as multiple agents targeting unique pathways of tumor growth and spread, he said.

Patients need to be given the various options that are available to them, said Dr. Strome. Physicians should let patients know the side effects of radiation, the potential 10% improvement in survival at three years with cetuximab and how these therapies compare with surgery. Chemotherapies are also becoming more effective, he said.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Departments, Head and Neck, Medical Education, Practice Focus Tagged With: cancer, carcinoma, outcomes, radiation, research, surgery, treatmentIssue: May 2006

You Might Also Like:

  • Targeted Therapies + Chemo Show Activity in Recurrent/Metastatic Head And Neck Cancer
  • New Treatment for Head and Neck Cancer Means Longer-Lasting Toxicity
  • A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use AI-powered scribes for documentation?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • How to: Positioning for Middle Cranial Fossa Repair of Superior Semicircular Canal Dehiscence

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • The Importance of Time Away
    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 
    • Reflections from a Past President of the Triological Society
    • ENT Surgeons Explore the Benefits and Challenges of AI-Powered Scribes: Revolutionizing Documentation in Healthcare
    • How To: Open Expansion Laryngoplasty for Combined Glottic and Subglottic Stenosis

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939